{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:41:34Z","timestamp":1790138494357,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"DOI":"10.1186\/s13027-025-00658-y","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:02:39Z","timestamp":1747994559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HTLV-1 infection and microRNAs: unraveling the complex crosstalk"],"prefix":"10.1186","volume":"20","author":[{"given":"Fahime","family":"Edalat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Letafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanin","family":"kaghazchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Shikki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Hossein","family":"Garkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Afrozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"658_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"key":"658_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.coviro.2015.09.004","volume":"14","author":"CR Bangham","year":"2015","unstructured":"Bangham CR, Ratner L. How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)? Curr Opin Virol. 2015;14:93\u2013100.","journal-title":"Curr Opin Virol"},{"key":"658_CR3","unstructured":"Durer C, Babiker HM. Adult T cell leukemia. 2020. https:\/\/europepmc.org\/article\/nbk\/nbk558968"},{"issue":"5","key":"658_CR4","first-page":"294","volume":"49","author":"M Davoudi","year":"2024","unstructured":"Davoudi M, Boostani R, Manzari ZS. Lived experience of human T-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): a phenomenology study. Iran J Med Sci. 2024;49(5):294.","journal-title":"Iran J Med Sci"},{"issue":"1\u20132","key":"658_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2014.03.025","volume":"104","author":"HT Fuzii","year":"2014","unstructured":"Fuzii HT, da Silva Dias GA, de Barros RJS, Falc\u00e3o LFM, Quaresma JAS. Immunopathogenesis of HTLV-1-assoaciated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Life Sci. 2014;104(1\u20132):9\u201314.","journal-title":"Life Sci"},{"key":"658_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","volume":"3","author":"M Yamagishi","year":"2012","unstructured":"Yamagishi M, Watanabe T. Molecular hallmarks of adult T cell leukemia. Front Microbiol. 2012;3:334.","journal-title":"Front Microbiol"},{"key":"658_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fgene.2012.00295","volume":"3","author":"GC Sampey","year":"2012","unstructured":"Sampey GC, Van Duyne R, Currer R, Das R, Narayanan A, Kashanchi F. Complex role of microRNAs in HTLV-1 infections. Front Genet. 2012;3:295.","journal-title":"Front Genet"},{"issue":"6","key":"658_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.autrev.2009.01.008","volume":"8","author":"C Carissimi","year":"2009","unstructured":"Carissimi C, Fulci V, Macino G. MicroRNAs: novel regulators of immunity. Autoimmun Rev. 2009;8(6):520\u20134.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"658_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.50.1","volume":"50","author":"Y Satou","year":"2010","unstructured":"Satou Y, Matsuoka M. HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases. J Clin Exp Hematop. 2010;50(1):1\u20138.","journal-title":"J Clin Exp Hematop"},{"issue":"12","key":"658_CR10","first-page":"1209","volume":"18","author":"MM Zadeh","year":"2015","unstructured":"Zadeh MM, Ranji N, Motamed N. Deregulation of miR-21 and miR-155 and their putative targets after silibinin treatment in T47D breast cancer cells. Iran J Basic Med Sci. 2015;18(12):1209.","journal-title":"Iran J Basic Med Sci"},{"issue":"9","key":"658_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/gad.1540407","volume":"21","author":"YS Lee","year":"2007","unstructured":"Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21(9):1025\u201330.","journal-title":"Genes Dev"},{"key":"658_CR12","first-page":"4452","volume":"20","author":"F-C Song","year":"2016","unstructured":"Song F-C, Yang Y, Liu J-X. Expression and significances of MiRNA Let-7 and HMGA2 in laryngeal carcinoma. Eur Rev Med Pharmacol Sci. 2016;20:4452\u201358.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"658_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neo.2015.04.005","volume":"17","author":"R Moles","year":"2015","unstructured":"Moles R, Bellon M, Nicot C. STAT1: A novel target of miR-150 and miR-223 is involved in the proliferation of HTLV-I\u2013transformed and ATL cells. Neoplasia. 2015;17(5):449\u201362.","journal-title":"Neoplasia"},{"key":"658_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-031-62558-9_9","volume-title":"Pathogens associated with the development of cancer in humans: OMICs, immunological, and pathophysiological studies","author":"JEH Madrid","year":"2024","unstructured":"Madrid JEH. The retrovirus human T cell leukemia virus type 1 (HTLV-1). In: Vel\u00e1zquez-M\u00e1rquez N, Paredes-Ju\u00e1rez GA, Vallejo-Ruiz V, editors. Pathogens associated with the development of cancer in humans: OMICs, immunological, and pathophysiological studies. Cham: Springer; 2024. p. 185\u2013202."},{"key":"658_CR15","volume-title":"Molecular mechanisms of monocyte depletion and CD4+ T-cell persistence during human T-cell leukemia virus infection","author":"A Sze","year":"2017","unstructured":"Sze A. Molecular mechanisms of monocyte depletion and CD4+ T-cell persistence during human T-cell leukemia virus infection. Montreal: McGill University (Canada); 2017."},{"issue":"8","key":"658_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/aps.2017.17","volume":"38","author":"L-L Zhang","year":"2017","unstructured":"Zhang L-L, Wei J-Y, Wang L, Huang S-L, Chen J-L. Human T-cell lymphotropic virus type 1 and its oncogenesis. Acta Pharmacol Sinica. 2017;38(8):1093\u2013103.","journal-title":"Acta Pharmacol Sinica"},{"issue":"5","key":"658_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.mam.2010.05.001","volume":"31","author":"K Ruggero","year":"2010","unstructured":"Ruggero K, Corradin A, Zanovello P, Amadori A, Bronte V, Ciminale V, et al. Role of microRNAs in HTLV-1 infection and transformation. Mol Aspects Med. 2010;31(5):367\u201382.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"658_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12977-024-00637-y","volume":"21","author":"SP Alpuche-Lazcano","year":"2024","unstructured":"Alpuche-Lazcano SP, Scarborough RJ, Gatignol A. MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV. Retrovirology. 2024;21(1):5.","journal-title":"Retrovirology"},{"issue":"1","key":"658_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/pathogens13010087","volume":"13","author":"M Bellon","year":"2024","unstructured":"Bellon M, Nicot C. HTLV-1 tax tug-of-war: cellular senescence and death or cellular transformation. Pathogens. 2024;13(1):87.","journal-title":"Pathogens"},{"issue":"4","key":"658_CR20","doi-asserted-by":"publisher","first-page":"e34490","DOI":"10.1371\/journal.pone.0034490","volume":"7","author":"S Rahman","year":"2012","unstructured":"Rahman S, Quann K, Pandya D, Singh S, Khan ZK, Jain P. HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS ONE. 2012;7(4):e34490.","journal-title":"PLoS ONE"},{"key":"658_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-016-0249-x","volume":"13","author":"G Ma","year":"2016","unstructured":"Ma G, Yasunaga J-I, Matsuoka M. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis. Retrovirology. 2016;13:1\u20139.","journal-title":"Retrovirology"},{"issue":"5","key":"658_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/rmv.1850","volume":"25","author":"L Wang","year":"2015","unstructured":"Wang L, Li G, Yao ZQ, Moorman JP, Ning S. MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV. Rev Med Virol. 2015;25(5):320\u201341.","journal-title":"Rev Med Virol"},{"key":"658_CR23","doi-asserted-by":"publisher","first-page":"624024","DOI":"10.3389\/fimmu.2021.624024","volume":"12","author":"Y-M Pers","year":"2021","unstructured":"Pers Y-M, Bony C, Duroux-Richard I, Bernard L, Maumus M, Assou S, et al. miR-155 contributes to the immunoregulatory function of human mesenchymal stem cells. Front Immunol. 2021;12:624024.","journal-title":"Front Immunol"},{"key":"658_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2043-9113-3-17","volume":"3","author":"G Higgs","year":"2013","unstructured":"Higgs G, Slack F. The multiple roles of microRNA-155 in oncogenesis. J Clin Bioinform. 2013;3:1\u20138.","journal-title":"J Clin Bioinform"},{"issue":"1","key":"658_CR25","first-page":"978607","volume":"2012","author":"M Tomita","year":"2012","unstructured":"Tomita M. Important roles of cellular MicroRNA miR-155 in leukemogenesis by human T-cell leukemia virus type 1 infection. Int Sch Res Notices. 2012;2012(1):978607.","journal-title":"Int Sch Res Notices"},{"issue":"2","key":"658_CR26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1074\/jbc.M707224200","volume":"283","author":"LB Frankel","year":"2008","unstructured":"Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283(2):1026\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"658_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1742-4690-5-101","volume":"5","author":"AB Bouzar","year":"2008","unstructured":"Bouzar AB, Willems L. How HTLV-1 may subvert miRNAs for persistence and transformation. Retrovirology. 2008;5(1):101.","journal-title":"Retrovirology"},{"issue":"21","key":"658_CR28","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","volume":"6","author":"S-M Park","year":"2007","unstructured":"Park S-M, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle. 2007;6(21):2585\u201390.","journal-title":"Cell Cycle"},{"key":"658_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0402-5","volume":"14","author":"T Wang","year":"2015","unstructured":"Wang T, Wang G, Hao D, Liu X, Wang D, Ning N, et al. Aberrant regulation of the LIN28A\/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer. Mol Cancer. 2015;14:1\u201313.","journal-title":"Mol Cancer"},{"key":"658_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00343-2","volume":"16","author":"A Nascimento","year":"2021","unstructured":"Nascimento A, Valadao de Souza DR, Pess\u00f4a R, Pietrobon AJ, Nukui Y, Pereira J, et al. Global expression of noncoding RNome reveals dysregulation of small RNAs in patients with HTLV-1\u2013associated adult T-cell leukemia: a pilot study. Infect Agents Cancer. 2021;16:1\u201313.","journal-title":"Infect Agents Cancer"},{"issue":"10","key":"658_CR31","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.3390\/ijms25105130","volume":"25","author":"M Bellon","year":"2024","unstructured":"Bellon M, Nicot C. Increased H19\/miR-675 expression in adult T-cell leukemia is associated with a unique notch signature pathway. Int J Mol Sci. 2024;25(10):5130.","journal-title":"Int J Mol Sci"},{"key":"658_CR32","doi-asserted-by":"publisher","first-page":"103938","DOI":"10.1016\/j.meegid.2019.103938","volume":"74","author":"M Fayyad-Kazan","year":"2019","unstructured":"Fayyad-Kazan M, ElDirani R, Hamade E, El Majzoub R, Akl H, Bitar N, et al. Circulating miR-29c, miR-30c, miR-193a-5p and miR-885-5p: Novel potential biomarkers for HTLV-1 infection diagnosis. Infect Genet Evol. 2019;74:103938.","journal-title":"Infect Genet Evol"},{"issue":"12","key":"658_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/v10120691","volume":"10","author":"N Futsch","year":"2018","unstructured":"Futsch N, Prates G, Mahieux R, Casseb J, Dutartre H. Cytokine networks dysregulation during HTLV-1 infection and associated diseases. Viruses. 2018;10(12):691.","journal-title":"Viruses"},{"issue":"10","key":"658_CR34","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.3390\/ijms23105486","volume":"23","author":"CB Machado","year":"2022","unstructured":"Machado CB, da Cunha LS, Mau\u00e9s JHS, Pessoa FMCdP, de Oliveira MB, Ribeiro RM, et al. Role of miRNAs in human T cell leukemia virus type 1 induced T cell leukemia: a literature review and bioinformatics approach. Int J Mol Sci. 2022;23(10):5486.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"658_CR35","first-page":"8060182","volume":"2016","author":"J Ye","year":"2016","unstructured":"Ye J, Guo R, Shi Y, Qi F, Guo C, Yang L. miR-155 regulated inflammation response by the SOCS1-STAT3-PDCD4 axis in atherogenesis. Mediat Inflamm. 2016;2016(1):8060182.","journal-title":"Mediat Inflamm"},{"issue":"10","key":"658_CR36","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/ijc.25115","volume":"130","author":"M Tomita","year":"2012","unstructured":"Tomita M, Tanaka Y, Mori N. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int J Cancer. 2012;130(10):2300\u20139.","journal-title":"Int J Cancer"},{"issue":"33","key":"658_CR37","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-\u03baB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci. 2006;103(33):12481\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"658_CR38","doi-asserted-by":"publisher","first-page":"974088","DOI":"10.3389\/fimmu.2022.974088","volume":"13","author":"DM D\u2019Agostino","year":"2022","unstructured":"D\u2019Agostino DM, Raimondi V, Silic-Benussi M, Ciminale V. MiR-150 in HTLV-1 infection and T-cell transformation. Front Immunol. 2022;13:974088.","journal-title":"Front Immunol"},{"key":"658_CR39","first-page":"1933","volume":"162","author":"X Lu","year":"2017","unstructured":"Lu X, Yang J, Wu H, Yang Z, Jin C, Wang J, et al. High-throughput sequencing identifies HIV-1-replication-and latency-related miRNAs in CD4+ T cell lines. Adv Virol. 2017;162:1933\u201342.","journal-title":"Adv Virol"},{"issue":"12","key":"658_CR40","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.7150\/jca.31361","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, Xu M, Ding L, Tang J. MiR-27a: a novel biomarker and potential therapeutic target in tumors. J Cancer. 2019;10(12):2836.","journal-title":"J Cancer"},{"issue":"9","key":"658_CR41","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.59876","volume":"17","author":"P Jiao","year":"2021","unstructured":"Jiao P, Wang X-P, Luoreng Z-M, Yang J, Jia L, Ma Y, et al. miR-223: an effective regulator of immune cell differentiation and inflammation. Int J Biol Sci. 2021;17(9):2308.","journal-title":"Int J Biol Sci"},{"key":"658_CR42","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fmicb.2018.00832","volume":"9","author":"VK Sharma","year":"2018","unstructured":"Sharma VK, Raimondi V, Ruggero K, Pise-Masison CA, Cavallari I, Silic-Benussi M, et al. Expression of miR-34a in T-cells infected by human T-lymphotropic virus 1. Front Microbiol. 2018;9:832.","journal-title":"Front Microbiol"},{"key":"658_CR43","doi-asserted-by":"publisher","first-page":"122973","DOI":"10.1016\/j.jns.2024.122973","volume":"459","author":"L Saab","year":"2024","unstructured":"Saab L, DiCapua D, Zubair AS. HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations. J Neurol Sci. 2024;459:122973.","journal-title":"J Neurol Sci"},{"issue":"15","key":"658_CR44","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.3390\/ijms25158191","volume":"25","author":"D Barbagallo","year":"2024","unstructured":"Barbagallo D, Ponti D, Bassani B, Bruno A, Pulze L, Akkihal SA, et al. MiR-223-3p in cancer development and cancer drug resistance: same coin, different faces. Int J Mol Sci. 2024;25(15):8191.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"658_CR45","first-page":"4001","volume":"60","author":"N Fernando","year":"2019","unstructured":"Fernando N, Wong J, Aggio-Bruce R, Wooff Y, Natoli RC. MicroRNA-223 regulates neuroinflammation in retinal degenerations. Investig Ophthalmol Vis Sci. 2019;60(9):4001.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"658_CR46","doi-asserted-by":"publisher","first-page":"106648","DOI":"10.1016\/j.nbd.2024.106648","volume":"200","author":"S Agostini","year":"2024","unstructured":"Agostini S, Mancuso R, Citterio LA, Caputo D, Oreni L, Nuzzi R, et al. Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis. Neurobiol Dis. 2024;200:106648.","journal-title":"Neurobiol Dis"},{"key":"658_CR47","doi-asserted-by":"publisher","first-page":"146327","DOI":"10.1016\/j.brainres.2019.146327","volume":"1721","author":"S Sarkar","year":"2019","unstructured":"Sarkar S, Engler-Chiurazzi E, Cavendish J, Povroznik J, Russell A, Quintana D, et al. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer\u2019s disease-like pathology. Brain Res. 2019;1721:146327.","journal-title":"Brain Res"},{"key":"658_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4531","volume":"16","author":"HM Jin","year":"2014","unstructured":"Jin HM, Kim T-J, Choi J-H, Kim M-J, Cho Y-N, Nam K-I, et al. MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis. Arthritis Res Ther. 2014;16:1\u20139.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"658_CR49","doi-asserted-by":"publisher","first-page":"e110267","DOI":"10.1371\/journal.pone.0110267","volume":"9","author":"O Peacock","year":"2014","unstructured":"Peacock O, Lee AC, Cameron F, Tarbox R, Vafadar-Isfahani N, Tufarelli C, et al. Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer. PLoS ONE. 2014;9(10):e110267.","journal-title":"PLoS ONE"},{"key":"658_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1590\/S0074-02762012000600020","volume":"107","author":"LDF Nicolete","year":"2012","unstructured":"Nicolete LDF, Nicolete R, Haddad R, Azevedo R, Castro FA, Tanaka Y, et al. Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy\/tropical spastic paraparesis patients. Memorias do Instituto Oswaldo Cruz. 2012;107:824\u20137.","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"658_CR51","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.mcn.2012.12.002","volume":"56","author":"U Bekenstein","year":"2013","unstructured":"Bekenstein U, Soreq H. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles. Mol Cell Neurosci. 2013;56:436\u201346.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"658_CR52","doi-asserted-by":"publisher","first-page":"2230015","DOI":"10.1080\/21505594.2023.2230015","volume":"14","author":"DRV de Souza","year":"2023","unstructured":"de Souza DRV, Pess\u00f4a R, Nukui Y, Pereira J, Marcusso RN, de Oliveira ACP, et al. Identification of miRnas with possible prognostic roles for HAM\/TSP. Virulence. 2023;14(1):2230015.","journal-title":"Virulence"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00658-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:05:12Z","timestamp":1748001912000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-025-00658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00658-y","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}